TP53 and neoplasm: In this report, the hypothesis that the primarily female specific hormone, estrogen, could affect tumorigenesis in p53-mutation carriers is tested though exploring possible interactions between MDM2 SNP309 locus and gender upon the age-dependent tumor incidence.